Page last updated: 2024-09-05

ly 353381 and Osteoporosis, Postmenopausal

ly 353381 has been researched along with Osteoporosis, Postmenopausal in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's3 (25.00)29.6817
2010's8 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arantes, HP; Bilezikian, JP; Chiang, AY; Gimeno, SG; Lazaretti-Castro, M1
Cox, DA; Downs, RW; Dowsett, SA; Ghosh, A; Harper, K; Moffett, AM1
Lewiecki, EM1
Amewou-Atisso, M; Christiansen, C; Cox, D; Cummings, SR; McClung, M; Miller, P; Mitlak, B; Powles, T; Reginster, JY; Stock, J; Zanchetta, J1
Alam, J; Cox, DA; Dowsett, SA; Kendler, DL; Palacios, S; Stock, J; Zanchetta, J1
Alam, J; Bhattoa, HP; Cox, DA; Dowsett, SA; Goldstein, SR; Muram, D; Neven, P; Sipos, A1
Chines, AA; Komm, BS1
Agnusdei, D; Amewou-Atisso, M; Cox, DA; Cummings, SR; Diem, SJ; Dowsett, SA; Fabian, CJ; Muram, D; Neven, P; Powles, TJ; Wickerham, DL1
Calaf Alsina, J; Coronado Martín, PJ1
Cox, DA; Hurn, PD; Littleton-Kearney, MT; Ostrowski, NL; Rossberg, MI1
Ohta, H1
Rowley, E; Sato, M; Turner, CH; Zeng, GQ1

Reviews

5 review(s) available for ly 353381 and Osteoporosis, Postmenopausal

ArticleYear
Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
    Journal of women's health (2002), 2009, Volume: 18, Issue:10

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Drug Therapy, Combination; Female; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Piperidines; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Vitamin D; Women's Health

2009
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.
    Maturitas, 2012, Volume: 71, Issue:3

    Topics: Bone Density Conservation Agents; Breast; Endometrium; Female; Fractures, Bone; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes

2012
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
    Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6

    Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism

2013
Selective estrogen receptor modulators: tissue actions and potential for CNS protection.
    CNS drug reviews, 2002,Fall, Volume: 8, Issue:3

    Topics: Animals; Breast Neoplasms; Cardiovascular System; Central Nervous System; Cognition; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Hypothalamo-Hypophyseal System; Male; Neuroprotective Agents; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Receptors, Neurotransmitter; Structure-Activity Relationship; Tamoxifen; Thiophenes; Uterus

2002
[Status of novel bone-targeting SERMs in development].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Nov-28, Volume: 65 Suppl 9

    Topics: Animals; Bone and Bones; Bone Density; Clinical Trials as Topic; Drug Design; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Receptors, Estrogen; Research; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Thiophenes

2007

Trials

5 trial(s) available for ly 353381 and Osteoporosis, Postmenopausal

ArticleYear
Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:7

    Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Dose-Response Relationship, Drug; Double-Blind Method; Endometrium; Female; Humans; Lipids; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Vasomotor System

2010
Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011, Volume: 26, Issue:2

    Topics: Aged; Aged, 80 and over; Bone Resorption; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Placebos; Postmenopause; Selective Estrogen Receptor Modulators; Thiophenes

2011
Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:3

    Topics: Absorptiometry, Photon; Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Double-Blind Method; Female; Femur Neck; Hip Joint; Hot Flashes; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Thiophenes; Treatment Outcome

2012
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass.
    Menopause (New York, N.Y.), 2012, Volume: 19, Issue:1

    Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Endometrium; Female; Genital Diseases, Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Placebos; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Uterine Hemorrhage; Vaginitis; Vulvitis

2012
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene.
    Breast cancer research and treatment, 2012, Volume: 134, Issue:1

    Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Double-Blind Method; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Postmenopause; Risk Factors; Thiophenes

2012

Other Studies

2 other study(ies) available for ly 353381 and Osteoporosis, Postmenopausal

ArticleYear
Incidence of vertebral fractures in calcium and vitamin D-supplemented postmenopausal Brazilian women with osteopenia or osteoporosis: data from Arzoxifene Generations Trial.
    Archives of endocrinology and metabolism, 2016, Volume: 60, Issue:1

    Topics: Age Distribution; Aged; Aged, 80 and over; Bone Diseases, Metabolic; Brazil; Calcium; Dietary Supplements; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Spinal Fractures; Thiophenes; Vitamin D

2016
LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
    Endocrinology, 1998, Volume: 139, Issue:11

    Topics: Animals; Biomechanical Phenomena; Body Weight; Bone Density; Estrogen Antagonists; Female; Humans; Organ Size; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone; Piperidines; Rats; Rats, Sprague-Dawley; Thiophenes; Tomography, X-Ray Computed

1998